Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2005-04-05
2005-04-05
Kunz, Gary (Department: 1647)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S188100, C514S002600
Reexamination Certificate
active
06875434
ABSTRACT:
Disclosed are pharmaceutical compositions and methods for preventing or treating a number of amyloid diseases, including Alzheimer's disesase, prion diseases, familial amyloid neuropathies and the like. The pharmaceutical compositions include immunologically reactive amounts of amyloid fibril components, particularly fibril-forming peptides or proteins. Also disclosed are therapeutic compositions and methods which use immune reagents that react with such fibril components.
REFERENCES:
patent: 4666829 (1987-05-01), Glenner et al.
patent: 5004697 (1991-04-01), Pardridge
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5187153 (1993-02-01), Cordell et al.
patent: 5192753 (1993-03-01), McGeer et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5220013 (1993-06-01), Ponte et al.
patent: 5231000 (1993-07-01), Majocha et al.
patent: 5231170 (1993-07-01), Averback
patent: 5270165 (1993-12-01), Van Nostrand et al.
patent: 5387742 (1995-02-01), Cordell
patent: 5434170 (1995-07-01), Andrulis, Jr.
patent: 5441870 (1995-08-01), Seubert et al.
patent: 5571499 (1996-11-01), Hafler et al.
patent: 5571500 (1996-11-01), Hafler et al.
patent: 5583112 (1996-12-01), Kensil et al.
patent: 5585100 (1996-12-01), Mond et al.
patent: 5593846 (1997-01-01), Schenk et al.
patent: 5605811 (1997-02-01), Seubert et al.
patent: 5612486 (1997-03-01), McConlogue et al.
patent: 5622701 (1997-04-01), Berg
patent: 5641473 (1997-06-01), Hafler et al.
patent: 5641474 (1997-06-01), Hafler et al.
patent: 5645820 (1997-07-01), Hafler et al.
patent: 5679348 (1997-10-01), Nesburn et al.
patent: 5688651 (1997-11-01), Solomon
patent: 5733547 (1998-03-01), Weiner et al.
patent: 5736142 (1998-04-01), Sette et al.
patent: 5744368 (1998-04-01), Goldgaber et al.
patent: 5750349 (1998-05-01), Suzuki et al.
patent: 5753624 (1998-05-01), McMichael et al.
patent: 5776468 (1998-07-01), Hauser et al.
patent: 5780587 (1998-07-01), Potter
patent: 5786180 (1998-07-01), Konig et al.
patent: 5824322 (1998-10-01), Balasubramanian
patent: 5837473 (1998-11-01), Maggio et al.
patent: 5837672 (1998-11-01), Schenk et al.
patent: 5849298 (1998-12-01), Weiner et al.
patent: 5851996 (1998-12-01), Kline
patent: 5854204 (1998-12-01), Findeis et al.
patent: 5869054 (1999-02-01), Weiner et al.
patent: 5869093 (1999-02-01), Weiner et al.
patent: 5877399 (1999-03-01), Hsiao et al.
patent: 5935927 (1999-08-01), Vitek et al.
patent: 5955079 (1999-09-01), Mond et al.
patent: 5955317 (1999-09-01), Suzuki et al.
patent: 5958883 (1999-09-01), Snow
patent: 5989566 (1999-11-01), Cobb et al.
patent: 6057367 (2000-05-01), Stamler et al.
patent: 6114133 (2000-09-01), Seubert et al.
patent: 6150091 (2000-11-01), Pandolfo et al.
patent: 6262335 (2001-07-01), Hsiao et al.
patent: 6284221 (2001-09-01), Schenk et al.
patent: 6294171 (2001-09-01), McMichael
patent: 6417178 (2002-07-01), Klunk et al.
patent: 20010018053 (2001-08-01), McMichael
patent: 20020009445 (2002-01-01), Du et al.
patent: 20020077288 (2002-06-01), Frangione
patent: 20020102261 (2002-08-01), Raso
patent: 20020136718 (2002-09-01), Raso
patent: 20020162129 (2002-10-01), Lannfelt
patent: 451 700 (1991-10-01), None
patent: 276 723 (1993-12-01), None
patent: 613 007 (1994-08-01), None
patent: 666 080 (1995-08-01), None
patent: 359 783 (1995-11-01), None
patent: 683 234 (1995-11-01), None
patent: 440 619 (1996-01-01), None
patent: 526 511 (1997-05-01), None
patent: 782 859 (1997-07-01), None
patent: 783 104 (1997-07-01), None
patent: 594 607 (1997-08-01), None
patent: 845 270 (1998-06-01), None
patent: 863 211 (1998-09-01), None
patent: 868 918 (1998-10-01), None
patent: 652 962 (1998-12-01), None
patent: 911 036 (1999-04-01), None
patent: 561 087 (1999-08-01), None
patent: 639 081 (1999-11-01), None
patent: 506 785 (2000-03-01), None
patent: 1 172 378 (2002-01-01), None
patent: 2 220 211 (1990-01-01), None
patent: 2 335 192 (1999-09-01), None
patent: 8810120 (1988-12-01), None
patent: 8901343 (1989-02-01), None
patent: 8903687 (1989-05-01), None
patent: 8906242 (1989-07-01), None
patent: 8906689 (1989-07-01), None
patent: 9012870 (1990-11-01), None
patent: 9012871 (1990-11-01), None
patent: 9108760 (1991-06-01), None
patent: 9112816 (1991-09-01), None
patent: 9116819 (1991-11-01), None
patent: 9119810 (1991-12-01), None
patent: 9206187 (1992-04-01), None
patent: 9206708 (1992-04-01), None
patent: 9213069 (1992-08-01), None
patent: 9302189 (1993-02-01), None
patent: 9304194 (1993-03-01), None
patent: 9314200 (1993-07-01), None
patent: 9315760 (1993-08-01), None
patent: 9316724 (1993-09-01), None
patent: 9321950 (1993-11-01), None
patent: 9401772 (1994-01-01), None
patent: 9403615 (1994-02-01), None
patent: 9428412 (1994-12-01), None
patent: 9504151 (1995-02-01), None
patent: 9505853 (1995-03-01), None
patent: WO 9511008 (1995-04-01), None
patent: 9511311 (1995-04-01), None
patent: 9511994 (1995-05-01), None
patent: 9512815 (1995-05-01), None
patent: 9531996 (1995-11-01), None
patent: 9618900 (1996-06-01), None
patent: 9625435 (1996-08-01), None
patent: 9628471 (1996-09-01), None
patent: 9639176 (1996-12-01), None
patent: 9717613 (1997-05-01), None
patent: 9721728 (1997-06-01), None
patent: 9807850 (1998-02-01), None
patent: 9844955 (1998-10-01), None
patent: 9900150 (1999-01-01), None
patent: 9906066 (1999-02-01), None
patent: WO 9906545 (1999-02-01), None
patent: 9927911 (1999-06-01), None
patent: 9927944 (1999-06-01), None
patent: 9927949 (1999-06-01), None
patent: WO 9906545 (1999-11-01), None
patent: 9958564 (1999-11-01), None
patent: 9960021 (1999-11-01), None
patent: 9960024 (1999-11-01), None
patent: WO 0162284 (2000-03-01), None
patent: WO 0043039 (2000-07-01), None
patent: 0043049 (2000-07-01), None
patent: WO 0072870 (2000-12-01), None
patent: 0077178 (2000-12-01), None
patent: WO 0072876 A2 (2000-12-01), None
patent: WO 0072880 A2 (2000-12-01), None
patent: WO 0203911 (2001-04-01), None
patent: WO 0139796 (2001-06-01), None
patent: WO 0142306 (2001-06-01), None
patent: WO 0162801 (2001-08-01), None
patent: WO 0177167 (2001-10-01), None
patent: WO 0190182 (2001-11-01), None
patent: WO 0234777 (2002-05-01), None
patent: WO 0234878 (2002-05-01), None
Jen et al. (1997) Preparation and Purification of antisera against different regions or isoforms of beta-amyloid precursor protein. Brain Research Protocols 2:23-30.*
Jobling et al, Mol. Microbiol., 1991, 5(7):1755-67.*
Skolnick and Fetrow (2000) From Genes to Protein Structure and Function: Novel Applications of Compuational Approaches in the Genomic Era. Trends in Biotech 18(1); 34-39.*
Chen et al. (1998) Neurodegenerative Alzheimer-like pathology in PDAPP 717V—F transgenico mice. Progress in Br. Res. 117:327-34.*
Tennent, Lovat, and Pepys (1995) Serum Amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. PNAS 92: 4299-4303.*
Stein and Johnson (2002) Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways. J Neuroscience 22 (17): 7380-7388.*
Tanaka et al. (1998) NC-1900, an a ctive fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats. European Journal of Pharmocolgy 352: 135-142.*
Esiri (2001) Is an Effective Immune Intervention for Alzheimer's Disease in Prospect? Trends in Pharm Science 22(1): 2-3.*
Younkin (2001) Amyloid beta Vaccination: Reduced Plaques and Improved Cognition. Nature Medicine 7(1):18-19.*
St-George-Hyslop and Westaway (1999) Antibody Clears Senile Plaques. Nature 400:116-117.*
ELAN “Elan and AHP Provide an Update on the Phase 2A Clinical Trial of AN-1792.” Press Release (Jan. 28, 2002).*
ELAN “Elan and Wyeth Provide Update on Status of Alzheimer's Collaboration” Press Release (Mar. 1, 2002).*
Frenkel et al. (1998) N-terminal EFRH Sequence of Alzheimer's beta-amyloid peptide represents the epitope of its anti-aggregating antibodies. Journal of Neuroimmunology 88:85-90.*
Frenkel et al. (2000) Immunization against Alzheimer's bet
Kunz Gary
Neuralab Limited
Nichols Christopher James
Townsend and Townsend / and Crew LLP
LandOfFree
Methods of treatment of Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment of Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment of Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3442040